Drawing for RESPIVAX

USPTO serial 87721290

RESPIVAX

Reviewed by CopyMark Law Group

Reg. 6048109Status 700Renewal
Filing date
Status date
Registration date
May 5, 2020
Examiner
LEE, DOUGLAS
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with RESPIVAX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $425

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Charles G. Zug

Charles G. Zug Nelson Mullins Riley & Scarborough LLP301 S. College St.Suite 2300, IP DepartmentCharlotte, NC 28202

Goods and services

ClassDescriptionStatusFirst use
005Veterinary preparations, namely, vaccines, oral and injectable antimicrobial preparations for the treatment of bovine respiratory disease, infectious bovine rhinotracheitis (IBR), bovine viral diarrhea (BVD 1 and BVD 2), bovine respiratory syncytial virus (BRSV), parainfluenza (PI3), pasteurella multocida, and mannheimia haemolytica; bacteriophage antimicrobials for the treatment of bovine respiratory disease, infectious bovine rhinotracheitis (IBR), bovine viral diarrhea (BVD 1 and BVD 2), bovine respiratory syncytial virus (BRSV), parainfluenza (PI3), pasteurella multocida, and mannheimia haemolytica; immunorestorative biopharmaceuticals for the treatment of bovine respiratory disease, infectious bovine rhinotracheitis (IBR), bovine viral diarrhea (BVD 1 and BVD 2), bovine respiratory syncytial virus (BRSV), parainfluenza (PI3), pasteurella multocida, and mannheimia haemolytica; parasiticides; insecticides; medicinal drugs for the treatment of bovine respiratory disease, infectious bovine rhinotracheitis (IBR), bovine viral diarrhea (BVD 1 and BVD 2), bovine respiratory syncytial virus (BRSV), parainfluenza (PI3), pasteurella multocida, and mannheimia haemolytica; dietary supplements; and hormone preparationsACTIVEJan 7, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 5, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 25, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 25, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 25, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 25, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 25, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 5, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 31, 2020SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Mar 30, 2020CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Mar 27, 2020SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Mar 27, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 10, 2020IUAFUSE AMENDMENT FILED—
Mar 10, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 16, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 14, 2019EX2GSOU EXTENSION 2 GRANTED—
Aug 14, 2019EXT2SOU EXTENSION 2 FILED—
Aug 14, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 12, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 8, 2019EX1GSOU EXTENSION 1 GRANTED—
Mar 8, 2019EXT1SOU EXTENSION 1 FILED—
Mar 8, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 31, 2018ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Sep 11, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 1, 2018ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Jun 18, 2018ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
May 22, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 22, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 2, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 16, 2018ALIEASSIGNED TO LIE—
Apr 10, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 2, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Apr 2, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 2, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 2, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 26, 2018DOCKASSIGNED TO EXAMINER—
Dec 29, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 18, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance